The board of directors of Seroja Investments Limited announced that the Company has incorporated a new wholly-owned subsidiary in Singapore. Details of the New Subsidiary are as follows:- Name of company: SEROJA BIOTECH PTE. LTD.; Place of incorporation: Singapore; Issued and paid-up share capital: 1 ordinary share at SGD1 each; Percentage of issued and paid-up share capital held by the Company: 100%; Principal activities: Research and experimental development on biotechnology, life and medical science. The incorporation of the New Subsidiary was funded by the Group's internal resources and is not expected to have any material impact on the Group's net tangible assets per share and earnings per share for the current financial year ending 31 December 2020.